Results 221 to 230 of about 933,480 (336)

Inequity in the use of physician services in Norway. Changing patterns over time [PDF]

We analyze and compare inequity in use of physician visits (GP and specialists) in Norway based on data from the Surveys of Living Conditions for the years 2000, 2002 and 2005.
Grasdal, Astrid, Monstad, Karin
core  

TRPM8 levels determine tumor vulnerability to channel agonists

Molecular Oncology, EarlyView.
TRPM8 is a Ca2+ permissive channel. Regardless of the amount of its transcript, high levels of TRPM8 protein mark different tumors, including prostate, breast, colorectal, and lung carcinomas. Targeting TRPM8 with channel agonists stimulates inward calcium currents followed by emptying of cytosolic Ca2+ stores in cancer cells.
Alessandro Alaimo, Francesco Giuseppe Carbone, Kristi Buzo, Nicole Annesi, Sacha Genovesi, Annalisa Lorenzato, Karen Widmann, Michela Libergoli, Elisa Marmocchi, Giovanni Bertalot, Alberto Brolese, Mauro Giulio Papotti, Luca Molinaro, Orazio Caffo, Mattia Barbareschi, Alberto Bardelli, Alessandro Romanel, Sabrina Arena, Andrea Lunardi   +18 more
wiley   +1 more source

Evaluating Health Plan Performance. Results of the 2000 Survey of Iowa Medicaid Managed Care Enrollees. Final Report to the Iowa Department of Human Services

, 2001
Elizabeth T. Momany, Margaret C. Tyler, Peter C. Damiano   +2 more
openalex   +2 more sources

Inequity in access to dental care services explains current socioeconomic disparities in oral health: The Swedish National Surveys of Public Health 2004-2005 [PDF]

, 2006
Sarah Wamala, Juan Merlo, Gustaf Boström   +2 more
openalex   +1 more source

Medicaid Crowd-Out of Private Long-Term Care Insurance Demand: Evidence from the Health and Retirement Survey [PDF]

, 2007
Jeffrey R. Brown, Norma B. Coe, Amy Finkelstein   +2 more
openalex   +2 more sources

Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer

Molecular Oncology, EarlyView.
Fibroblasts, cells in the tumor environment, support ovarian cancer cell growth and alter morphology and drug response. We used fibroblast and cancer cell co‐culture models to test 528 drugs and discovered new drugs for combination treatment. We showed that adding Vorinostat or Birinapant to standard chemotherapy may improve drug response, suggesting ...
Greta Gudoityte, Osheen Sharma, Laura Leuenberger, Emelie Wallin, Josefin Fernebro, Päivi Östling, Rebecka Bergström, Johan Lindberg, Ulrika Joneborg, Olli Kallioniemi, Brinton Seashore‐Ludlow   +10 more
wiley   +1 more source

N-terminal pro brain natriuretic peptide plasma level is dependent of age and gender: A survey of a large urban population aged older than fifty years Ilan Raymond, Bjoern A. Groenning, Frants Pedersen, Jeanett Dimsits, Matthias Baumann, J�rgen Trawinski, Per R. Hildebrandt. Department of Cardiology and Endocrinology, H:S Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark, Integrated Health Care Solutions, F. Hoffmann-La Roche Ltd, Basel, Switzerland

, 2001

openalex   +1 more source

Setting directions for capacity building in primary health care: a survey of a research network [PDF]

, 2006
Karin Ried, Elizabeth Farmer, Kathryn M Weston   +2 more
openalex   +1 more source

"On the Consumption Insurance Effects of Long-term Care Insurance In Japan: Evidence from Micro Household Data" [PDF]

Using micro-level household data in the 2001 Comprehensive Survey of the Living Conditions of the People on Health and Welfare as compiled by the Japanese Ministry of Health, Labor and Welfare, this paper examines how having a household member in need of
Makoto Saito, Miki Kohara, Yasushi Iwamoto   +2 more
core  

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source